< Terug naar vorige pagina


Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

Tijdschriftbijdrage - Tijdschriftartikel

BACKGROUND: We investigated prognostic factors (PFs) for 90-day mortality in a large cohort of advanced/metastatic soft tissue sarcoma (STS) patients treated with first-line chemotherapy.
Tijdschrift: British Journal of Cancer
ISSN: 0007-0920
Issue: 10
Volume: 104
Pagina's: 1544 - 1550
Jaar van publicatie:2011
BOF-publication weight:2
CSS-citation score:1
Authors from:Higher Education